356 related articles for article (PubMed ID: 7543605)
41. Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges.
Meshref AW; Bazinet M; Trudel C; Aronson S; Peloquin F; Nachabe M; Dessureault J; Aprikian AG; Begin LR; Elhilali MM
Urology; 1995 Jun; 45(6):972-9. PubMed ID: 7539562
[TBL] [Abstract][Full Text] [Related]
42. A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer.
Mitchell ID; Croal BL; Dickie A; Cohen NP; Ross I
J Urol; 2001 May; 165(5):1549-53. PubMed ID: 11342915
[TBL] [Abstract][Full Text] [Related]
43. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA
Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929
[TBL] [Abstract][Full Text] [Related]
44. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.
Brawer MK; Cheli CD; Neaman IE; Goldblatt J; Smith C; Schwartz MK; Bruzek DJ; Morris DL; Sokoll LJ; Chan DW; Yeung KK; Partin AW; Allard WJ
J Urol; 2000 May; 163(5):1476-80. PubMed ID: 10751861
[TBL] [Abstract][Full Text] [Related]
45. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
[TBL] [Abstract][Full Text] [Related]
46. [Detection of prostate cancer in urological practice: clinical establishment of serum PSA reference values by age].
Yamazaki H; Suzuki Y; Madarame A; Katoh N; Masuda F; Ohishi ; Endo K
Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):702-9. PubMed ID: 8709448
[TBL] [Abstract][Full Text] [Related]
47. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
48. Free to complexed PSA ratio in differentiating benign prostate hyperplasia from prostate cancer.
Filella X; Alcover J; Corral JM; Molina R; Beardo P; Ballesta AM
Anticancer Res; 2001; 21(5):3717-20. PubMed ID: 11848550
[TBL] [Abstract][Full Text] [Related]
49. Ethnic differences in the age-related distribution of serum prostate-specific antigen values: a study in a healthy Korean male population.
Lee SE; Kwak C; Park MS; Lee CH; Kang W; Oh SJ
Urology; 2000 Dec; 56(6):1007-10. PubMed ID: 11113748
[TBL] [Abstract][Full Text] [Related]
50. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels.
Ornstein DK; Rao GS; Smith DS; Ratliff TL; Basler JW; Catalona WJ
J Urol; 1997 Jan; 157(1):195-8. PubMed ID: 8976249
[TBL] [Abstract][Full Text] [Related]
51. Molecular forms of serum prostate-specific antigen: the clinical usefulness of percent free PSA to discriminate prostate cancer from BPH.
Abrahamsson PA; Kuriyama M
Hinyokika Kiyo; 1998 Apr; 44(4):223-32. PubMed ID: 9617617
[TBL] [Abstract][Full Text] [Related]
52. Can free and total prostate specific antigen and prostatic volume distinguish between men with negative and positive systematic ultrasound guided prostate biopsies?
Prestigiacomo AF; Stamey TA
J Urol; 1997 Jan; 157(1):189-94. PubMed ID: 8976248
[TBL] [Abstract][Full Text] [Related]
53. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
Haese A; Dworschack RT; Partin AW
J Urol; 2002 Aug; 168(2):504-8. PubMed ID: 12131298
[TBL] [Abstract][Full Text] [Related]
54. Optimum PSA reflex-range.
Benecchi L
Arch Ital Urol Androl; 2006 Jun; 78(2):44-8. PubMed ID: 16929601
[TBL] [Abstract][Full Text] [Related]
55. Distribution of serum prostate-specific antigen in healthy Korean men: influence of ethnicity.
Ku JH; Ahn JO; Lee CH; Lee NK; Park YH; Byun SS; Kwak C; Lee SE
Urology; 2002 Sep; 60(3):475-9. PubMed ID: 12350489
[TBL] [Abstract][Full Text] [Related]
56. Clinical evaluation of serum prostate-specific antigen-alpha1-antichymotrypsin complex values in diagnosis of prostate cancer: a cooperative study.
Kuriyama M; Ueno K; Uno H; Kawada Y; Akimoto S; Noda M; Nasu Y; Tsushima T; Ohmori H; Sakai H; Saito Y; Meguro N; Usami M; Kotake T; Suzuki Y; Arai Y; Shimazaki J
Int J Urol; 1998 Jan; 5(1):48-54. PubMed ID: 9535601
[TBL] [Abstract][Full Text] [Related]
57. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer.
Christensson A; Björk T; Nilsson O; Dahlén U; Matikainen MT; Cockett AT; Abrahamsson PA; Lilja H
J Urol; 1993 Jul; 150(1):100-5. PubMed ID: 7685416
[TBL] [Abstract][Full Text] [Related]
58. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
[TBL] [Abstract][Full Text] [Related]
59. The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer.
Partin AW; Carter HB
Urol Clin North Am; 1996 Nov; 23(4):531-40. PubMed ID: 8948408
[TBL] [Abstract][Full Text] [Related]
60. Free/total prostate-specific antigen ratio--hope and controversies.
Ravery V; Boccon-Gibod L
Eur Urol; 1997; 31(4):385-8. PubMed ID: 9187894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
